Quality of life in newly diagnosed lung cancer patients

Introduction: Lung cancer is the most common cause of death among all malignant neoplasm in men. Most of lung cancer patients are diagnosed in advanced stage, which requiers different treatment modalities (chemotherapy and/or radiotherapy) and has a high mortality rate. Some studies suggest that initial Quality of Life (QOL) is a strong prognostic factor for survival in lung cancer. Proper evaluation of QOL leads to improvement of QLL, especially in patients with terminal stage illness, and is an important part of supportive and palliative management of these patients.Aims and Objectives: To examine the initial QOL in newly diagnosed advanced lung cancer patients.Methods: Observational stutudy included patients with histologically diagnosed advanced lung cancer within 8 weeks of diagnosis. To assess patients'QOL, we used the SF36 questonnaire. Chisquared test (x2test) was used for statistical analysis and p
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Epidemiology Source Type: research

Related Links:

Introduction: Lung cancer patients require a structured screening and assessment to ensure their complex needs are detected. HNA offers the opportunity to strengthen and enhance the experience of care across health and social/spiritual care within a nurse led service.Aim: To present our experience of HNA in a socioeconomically and ethnically diverse area.Materials and methods: Retrospective review of all patients that underwent HNA from August to December 2017 (ethnicity, religion, social deprivation, concerns/needs).Results: HNA was offered to 38 patients diagnosed with lung cancer (27 males, 11 females, mean age 66.8, ag...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Nurses Source Type: research
Conclusion: This study emphasizes the impact of comorbidities and its real burden in COPD. For better outcomes and quality of life each comorbidity should be individually assessed and treated
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Clinical Problems Source Type: research
Background: Personalised therapy for COPD patients is debated. We investigated whether the rate of FEV1 decline differs between patients with and without ICS-containing medications, stratified by blood EOS level.Methods: The UK Clinical Practice Research Datalink (primary care records) and Hospital Episode Statistics (hospital records) were used to identify COPD patients with ≥2 FEV1 measurements ≥6 months apart. Follow-up started from first FEV1 until censoring at death, leaving database or first ICS-containing prescription (if not baseline ICS-containing user). The nearest blood EOS 2 years prior to the start of fo...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Epidemiology Source Type: research
Conclusion.Substantial proportions of advanced lung cancer patients and their caregivers misunderstood their prognosis. Interventions to improve their accurate prognostic understanding should be developed with careful attention paid to its associated factors.Implications for Practice.This study demonstrated that substantial proportions of patients with newly diagnosed advanced lung cancer and their caregivers had misunderstandings about their prognosis. Accurate perceptions of prognosis, which are indispensable in the delivery of effective care, were associated with elevated levels of anxiety and depression in both patient...
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Lung Cancer, Symptom Management and Supportive Care Source Type: research
This study aimed to generate real-world evidence to assess the burden of comorbidities in COPD patients, to effectively manage these patients and optimize the associated healthcare resource allocation. ARCTIC is a large, real-world, retrospective cohort study conducted in Swedish COPD patients using electronic medical record data collected between 2000 and 2014. These patients were studied for prevalence of various comorbidities and for association of these comorbidities with exacerbations, mortality, and healthcare costs compared with an age-, sex-, and comorbidities-matched non-COPD reference population. A total of 17,47...
Source: Primary Care - Category: Primary Care Authors: Tags: NPJ Prim Care Respir Med Source Type: research
This study was conducted to evaluate the efficacy of olanzapine (5 mg) combined with 5-HT3 receptor antagonists and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in lung patients receiving cisplatin-based (25 mg/m2 d1-3) highly emetogenic chemotherapy (HEC). Olanzapine (5 mg) was administered a day prior to cisplatin administration and continued on days 1 to 5. We evaluated complete response (CR) rate and rates of no nausea and no vomiting in 3 periods. In addition, Self-Rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS), and The Functional Living Index-Emesis (FLIE)...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research
ConclusionsHope and optimism appear to be associated with different aspects of psychological distress in patients living with advanced cancer. This may be explained by different appraisals of the uncertainty and distress that are associated with living with advanced-stage cancer. Hope- or optimism-focused interventions can be tailored to help alleviate specific aspects of psychological distress among these patients.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
CONCLUSION: Substantial proportions of advanced lung cancer patients and their caregivers misunderstood their prognosis. Interventions to improve their accurate prognostic understanding should be developed with careful attention paid to its associated factors. IMPLICATIONS FOR PRACTICE: This study demonstrated that substantial proportions of patients with newly diagnosed advanced lung cancer and their caregivers had misunderstandings about their prognosis. Accurate perceptions of prognosis, which are indispensable in the delivery of effective care, were associated with elevated levels of anxiety and depression in both...
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Oncologist Source Type: research
Authors: Mjid M, Slim A, Hrizi D, Hedhli A, Cheikh Rouhou S, Ouahchi Y, Toujani S, Cherif J Abstract INTRODUCTION: Sleep disorders are relatively common in oncology. However, they have not been well studied and are often treated insufficiently. AIM: To assess the prevalence and severity of insomnia in lung cancer patients and evaluate the relationship between insomnia and certain clinical parameters. METHODS: A cross-sectional study was undertaken of patients in Tunis with primary lung cancer. Socio-demographic and clinical data were obtained from the medical records Patients were then asked to answer quest...
Source: Revue des Maladies Respiratoires - Category: Respiratory Medicine Tags: Rev Mal Respir Source Type: research
It ’s difficult to open a newspaper nowadays without seeing an article about artificial intelligence. These column-inches spark our imaginations with heady visions of possible futures and crease our brows with concern in equal measure. But one thing you cannot escape is that AI is here now and it’s only going to become more pervasive.While fear of an unknown technology is understandable, in many ways it does a disservice to the incredible impact that AI is already having on the world around us. In the healthcare space alone, it is offering ways to fundamentally rethink clinical practice, speeding up diagnosis, ...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news
More News: Anxiety | Cancer | Cancer & Oncology | Chemotherapy | Depression | Epidemiology | Lung Cancer | Palliative | Respiratory Medicine | Statistics | Study